| Identification | |
| Name: | 17-PA |
| Synonyms: | 17-PA;17-PHENYL-(3A,5A)-ANDROST-16-EN-3-OL |
| CAS: | 694438-95-4 |
| Molecular Formula: | C25H34O |
| Molecular Weight: | 0 |
| InChI: | InChI=1/C25H34O/c1-24-14-12-19(26)16-18(24)8-9-20-22-11-10-21(17-6-4-3-5-7-17)25(22,2)15-13-23(20)24/h3-7,10,18-20,22-23,26H,8-9,11-16H2,1-2H3/t18-,19+,20-,22-,23-,24-,25+/m0/s1 |
| Molecular Structure: |  |
| Properties | |
| Flash Point: | 197.4°C |
| Boiling Point: | 472.9°C at 760 mmHg |
| Density: | 1.073g/cm3 |
| Refractive index: | 1.571 |
| Biological Activity: | Selective antagonist of neurosteroid potentiation and direct gating of GABA A receptors. Selectively reduces the effects of 5 α -reduced steroids compared to 5 β -reduced steroids and displays no effect on potentiation evoked by barbiturates and benzodiazepines. Attenuates 3 α ,5 α -THP-induced loss of righting reflex and total sleep time following i.c.v administration in rats. |
| Flash Point: | 197.4°C |
| Safety Data | |
 |
|
